Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05745389 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry

StatusRecruiting
PhaseNot specified
SponsorCorEvitas
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Re-verified, no change to tracked fieldsv5
  2. Minor Trial status: Enrolling by Invitation to Recruiting
    • Site details revised
    v4
  3. Minor 2 versions Re-verified since May 4, 2023, no change to tracked fieldsv2-v3
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
24 trials monitored
See all monitored trials
Prospective, observational cohort study for subjects with AA under the care of a dermatology provider. Approximately 5,000 subjects and 100 clinical sites in North America will be recruited to participate with no defined upper limit for either target.
Trial Details
NCT Number NCT05745389
Lead Sponsor CorEvitas
Conditions
(from sponsor)
Alopecia Areata
Related terms Alopecia Areata
Enrollment 5,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov